Articles by Arturo Hurtado, MD, MHSc

• 

  News
  An Early Warning System: How Continuous MRD Testing Can Predict Myeloma Relapse Years in Advance
  Oct 10, 2025
• 

  News
  ¿Existe una Relación Entre el Número de Medicamentos Utilizados y el Nivel de Riesgo de Mieloma Múltiple?
  Feb 20, 2024
• 

  News
  Ensayo Clínico: Isatuximab en la Gammapatía Monoclonal de Significado Renal (GMSR)
  Feb 05, 2024
• 

  News
  Boosting Quality of Life and Immune Function with Non-Chemotherapy Interventions for Multiple Myeloma
  Jul 25, 2023
• 

  News
  Ensayo clínico: transplante alogénico frente a autotransplante en el mieloma múltiple
  Jun 29, 2023
• 

  News
  Clinical Trial: Boosting Quality of Life and Immune Function with Non-Chemotherapy Approaches for Multiple Myeloma
  May 21, 2023
• 

  News
  Ensayo clínico: un CAR-T alogénico para el mieloma
  Mar 02, 2023
• 

  News
  Clinical Trial: Isatuximab in Monoclonal Gammopathy of Renal Significance (MGRS)
  Feb 01, 2023
• 

  News
  Clinical Trial: Allo vs. Auto Transplant in Multiple Myeloma
  Dec 07, 2022
• 

  News
  Clinical Trial: An Allogeneic CAR-T for Myeloma
  Aug 30, 2022
• 

  News
  Quality of Life After Stem Cell Transplant for Myeloma Patients
  Jun 02, 2022
• 

  News
  Real-World Data on CAR T-Cell Therapy in Multiple Myeloma
  May 23, 2022